$LXP
LXP Industrial Trust

2023 Q2 Form 10-Q Financial Statement

#000144483823000011 Filed on May 03, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2023 Q1
Revenue $87.05M $85.08M
YoY Change 9.12% 5.98%
Cost Of Revenue $14.86M $14.35M
YoY Change 15.94% 4.52%
Gross Profit $72.19M $70.73M
YoY Change 7.81% 6.28%
Gross Profit Margin 82.93% 83.13%
Selling, General & Admin $9.895M $10.14M
YoY Change -2.81% -12.8%
% of Gross Profit 13.71% 14.33%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $45.99M $45.74M
YoY Change 1.77% 2.77%
% of Gross Profit 63.71% 64.67%
Operating Expenses $55.78M $55.96M
YoY Change 0.73% -0.31%
Operating Profit $16.41M $14.77M
YoY Change 41.68% 41.76%
Interest Expense -$10.14M $11.39M
YoY Change -193.74% 6.66%
% of Operating Profit -61.81% 77.14%
Other Income/Expense, Net $143.0K $194.0K
YoY Change 81.01% 506.25%
Pretax Income -$6.556M $7.927M
YoY Change -118.12% 32929.17%
Income Tax $210.0K $216.0K
% Of Pretax Income 2.72%
Net Earnings -$9.683M $11.17M
YoY Change -123.45% 5.12%
Net Earnings / Revenue -11.12% 13.12%
Basic Earnings Per Share -$0.03 $0.03
Diluted Earnings Per Share -$0.03 $0.03
COMMON SHARES
Basic Shares Outstanding 292.6M shares 292.6M shares
Diluted Shares Outstanding 291.0M shares 291.0M shares

Balance Sheet

Concept 2023 Q2 2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $23.16M $42.92M
YoY Change -53.51% -12.51%
Cash & Equivalents $23.16M $42.92M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables $81.59M $4.141M
Other Receivables $0.00 $0.00
Total Short-Term Assets $104.8M $121.5M
YoY Change -12.58% 1.33%
LONG-TERM ASSETS
Property, Plant & Equipment $3.698B $3.735B
YoY Change -0.52% 2.37%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $50.68M $52.57M
YoY Change -14.29% -28.55%
Other Assets $81.33M $69.89M
YoY Change -40.75% -45.65%
Total Long-Term Assets $3.858B $3.884B
YoY Change -1.95% 0.41%
TOTAL ASSETS
Total Short-Term Assets $104.8M $121.5M
Total Long-Term Assets $3.858B $3.884B
Total Assets $3.962B $4.005B
YoY Change -2.27% 0.44%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $64.40M $57.17M
YoY Change -21.26% -12.76%
Accrued Expenses $31.54M $34.42M
YoY Change -9.71% -10.11%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $134.2M $129.8M
YoY Change -11.88% -7.72%
LONG-TERM LIABILITIES
Long-Term Debt $1.483B $1.486B
YoY Change -8.02% -0.61%
Other Long-Term Liabilities $26.25M $28.84M
YoY Change -12.13% -8.76%
Total Long-Term Liabilities $1.510B $1.515B
YoY Change -8.09% -0.78%
TOTAL LIABILITIES
Total Short-Term Liabilities $134.2M $129.8M
Total Long-Term Liabilities $1.510B $1.515B
Total Liabilities $1.682B $1.644B
YoY Change -6.3% -1.36%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock $29.00K $29.00K
YoY Change 3.57% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $2.281B $2.323B
YoY Change
Total Liabilities & Shareholders Equity $3.962B $4.005B
YoY Change -2.27% 0.44%

Cashflow Statement

Concept 2023 Q2 2023 Q1
OPERATING ACTIVITIES
Net Income -$9.683M $11.17M
YoY Change -123.45% 5.12%
Depreciation, Depletion And Amortization $45.99M $45.74M
YoY Change 1.77% 2.77%
Cash From Operating Activities $55.10M $37.55M
YoY Change 3.73% -10.8%
INVESTING ACTIVITIES
Capital Expenditures $32.60M $37.96M
YoY Change -125.2% -124.73%
Acquisitions
YoY Change
Other Investing Activities -$751.0K $32.43M
YoY Change -101.16% 3226.15%
Cash From Investing Activities -$33.35M -$5.529M
YoY Change -48.36% -96.38%
FINANCING ACTIVITIES
Cash Dividend Paid $38.21M
YoY Change 3.75%
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -41.50M -$43.48M
YoY Change -439.61% 38.4%
NET CHANGE
Cash From Operating Activities 55.10M $37.55M
Cash From Investing Activities -33.35M -$5.529M
Cash From Financing Activities -41.50M -$43.48M
Net Change In Cash -19.76M -$11.46M
YoY Change -2706.6% -91.92%
FREE CASH FLOW
Cash From Operating Activities $55.10M $37.55M
Capital Expenditures $32.60M $37.96M
Free Cash Flow $22.50M -$413.0K
YoY Change -87.67% -100.21%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q1 dei Entity Central Index Key
EntityCentralIndexKey
0000910108
CY2023Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q1 dei Amendment Flag
AmendmentFlag
false
CY2023Q1 dei Document Type
DocumentType
10-Q
CY2023Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2023Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q1 dei Entity File Number
EntityFileNumber
1-12386
CY2023Q1 dei Entity Registrant Name
EntityRegistrantName
LXP INDUSTRIAL TRUST
CY2023Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
MD
CY2023Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
13-3717318
CY2023Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
One Penn Plaza, Suite 4015
CY2023Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
New York
CY2023Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
NY
CY2023Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
10119-4015
CY2023Q1 dei City Area Code
CityAreaCode
212
CY2023Q1 dei Local Phone Number
LocalPhoneNumber
692-7200
CY2023Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q1 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2023Q1 dei Entity Small Business
EntitySmallBusiness
false
CY2023Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023Q1 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
292580615 shares
CY2023Q1 us-gaap Real Estate Investment Property At Cost
RealEstateInvestmentPropertyAtCost
3732558000 usd
CY2022Q4 us-gaap Real Estate Investment Property At Cost
RealEstateInvestmentPropertyAtCost
3691066000 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
328607000 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
328607000 usd
CY2023Q1 us-gaap Inventory Land Held For Development And Sale
InventoryLandHeldForDevelopmentAndSale
84507000 usd
CY2022Q4 us-gaap Inventory Land Held For Development And Sale
InventoryLandHeldForDevelopmentAndSale
84412000 usd
CY2023Q1 us-gaap Construction In Progress Gross
ConstructionInProgressGross
349827000 usd
CY2022Q4 us-gaap Construction In Progress Gross
ConstructionInProgressGross
361924000 usd
CY2023Q1 lxp Real Estate Investment Property Finite Lived Intangible Assets And Construction In Progress Gross
RealEstateInvestmentPropertyFiniteLivedIntangibleAssetsAndConstructionInProgressGross
4495499000 usd
CY2022Q4 lxp Real Estate Investment Property Finite Lived Intangible Assets And Construction In Progress Gross
RealEstateInvestmentPropertyFiniteLivedIntangibleAssetsAndConstructionInProgressGross
4466009000 usd
CY2023Q1 lxp Real Estate Investment Property Accumulated Depreciation And Amortization
RealEstateInvestmentPropertyAccumulatedDepreciationAndAmortization
845338000 usd
CY2022Q4 lxp Real Estate Investment Property Accumulated Depreciation And Amortization
RealEstateInvestmentPropertyAccumulatedDepreciationAndAmortization
800470000 usd
CY2023Q1 us-gaap Real Estate Investment Property Net
RealEstateInvestmentPropertyNet
3650161000 usd
CY2022Q4 us-gaap Real Estate Investment Property Net
RealEstateInvestmentPropertyNet
3665539000 usd
CY2023Q1 us-gaap Disposal Group Including Discontinued Operation Assets Noncurrent
DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent
44286000 usd
CY2022Q4 us-gaap Disposal Group Including Discontinued Operation Assets Noncurrent
DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent
66434000 usd
CY2023Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
22967000 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
23986000 usd
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
42923000 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
54390000 usd
CY2023Q1 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
120000 usd
CY2022Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
116000 usd
CY2023Q1 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
52571000 usd
CY2022Q4 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
58206000 usd
CY2023Q1 us-gaap Deferred Costs Current And Noncurrent
DeferredCostsCurrentAndNoncurrent
25485000 usd
CY2022Q4 us-gaap Deferred Costs Current And Noncurrent
DeferredCostsCurrentAndNoncurrent
25207000 usd
CY2023Q1 us-gaap Sales Type Lease Net Investment In Lease Allowance For Credit Loss
SalesTypeLeaseNetInvestmentInLeaseAllowanceForCreditLoss
172000 usd
CY2022Q4 us-gaap Sales Type Lease Net Investment In Lease Allowance For Credit Loss
SalesTypeLeaseNetInvestmentInLeaseAllowanceForCreditLoss
93000 usd
CY2023Q1 us-gaap Sales Type Lease Net Investment In Lease After Allowance For Credit Loss
SalesTypeLeaseNetInvestmentInLeaseAfterAllowanceForCreditLoss
61680000 usd
CY2022Q4 us-gaap Sales Type Lease Net Investment In Lease After Allowance For Credit Loss
SalesTypeLeaseNetInvestmentInLeaseAfterAllowanceForCreditLoss
61233000 usd
CY2023Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
4141000 usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
3030000 usd
CY2023Q1 us-gaap Deferred Rent Receivables Net
DeferredRentReceivablesNet
74394000 usd
CY2022Q4 us-gaap Deferred Rent Receivables Net
DeferredRentReceivablesNet
71392000 usd
CY2023Q1 us-gaap Other Assets
OtherAssets
26353000 usd
CY2022Q4 us-gaap Other Assets
OtherAssets
24314000 usd
CY2023Q1 us-gaap Assets
Assets
4005081000 usd
CY2022Q4 us-gaap Assets
Assets
4053847000 usd
CY2023Q1 us-gaap Secured Debt
SecuredDebt
69288000 usd
CY2022Q4 us-gaap Secured Debt
SecuredDebt
72103000 usd
CY2023Q1 us-gaap Loans Payable To Bank
LoansPayableToBank
299084000 usd
CY2022Q4 us-gaap Loans Payable To Bank
LoansPayableToBank
298959000 usd
CY2023Q1 us-gaap Senior Notes
SeniorNotes
989636000 usd
CY2022Q4 us-gaap Senior Notes
SeniorNotes
989295000 usd
CY2023Q1 us-gaap Unsecured Debt
UnsecuredDebt
127719000 usd
CY2022Q4 us-gaap Unsecured Debt
UnsecuredDebt
127694000 usd
CY2023Q1 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
38164000 usd
CY2022Q4 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
38416000 usd
CY2023Q1 us-gaap Liabilities Of Disposal Group Including Discontinued Operation
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation
1889000 usd
CY2022Q4 us-gaap Liabilities Of Disposal Group Including Discontinued Operation
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation
1150000 usd
CY2023Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
23985000 usd
CY2022Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
25118000 usd
CY2023Q1 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
57170000 usd
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
74261000 usd
CY2023Q1 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
10431000 usd
CY2022Q4 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
9181000 usd
CY2023Q1 us-gaap Deferred Income
DeferredIncome
10959000 usd
CY2022Q4 us-gaap Deferred Income
DeferredIncome
11452000 usd
CY2023Q1 us-gaap Advance Rent
AdvanceRent
15994000 usd
CY2022Q4 us-gaap Advance Rent
AdvanceRent
15215000 usd
CY2023Q1 us-gaap Liabilities
Liabilities
1644319000 usd
CY2022Q4 us-gaap Liabilities
Liabilities
1662844000 usd
CY2023Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000000 shares
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000000 shares
CY2022Q4 us-gaap Preferred Stock Liquidation Preference Value
PreferredStockLiquidationPreferenceValue
96770000 usd
CY2023Q1 us-gaap Preferred Stock Liquidation Preference Value
PreferredStockLiquidationPreferenceValue
96770000 usd
CY2023Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
1935400 shares
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
1935400 shares
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
1935400 shares
CY2023Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
1935400 shares
CY2023Q1 us-gaap Preferred Stock Value
PreferredStockValue
94016000 usd
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
94016000 usd
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
600000000 shares
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
600000000 shares
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
292557721 shares
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
292557721 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
291719310 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
291719310 shares
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
29000 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
29000 usd
CY2023Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
3320185000 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
3320087000 usd
CY2023Q1 us-gaap Accumulated Distributions In Excess Of Net Income
AccumulatedDistributionsInExcessOfNetIncome
1105875000 usd
CY2022Q4 us-gaap Accumulated Distributions In Excess Of Net Income
AccumulatedDistributionsInExcessOfNetIncome
1079087000 usd
CY2023Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
14169000 usd
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
17689000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
2322524000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
2352734000 usd
CY2023Q1 us-gaap Minority Interest
MinorityInterest
38238000 usd
CY2022Q4 us-gaap Minority Interest
MinorityInterest
38269000 usd
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
2360762000 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
2391003000 usd
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
4005081000 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
4053847000 usd
CY2023Q1 us-gaap Lease Income
LeaseIncome
83417000 usd
CY2022Q1 us-gaap Lease Income
LeaseIncome
78536000 usd
CY2023Q1 us-gaap Revenues
Revenues
85075000 usd
CY2022Q1 us-gaap Revenues
Revenues
80278000 usd
CY2023Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
45741000 usd
CY2022Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
44506000 usd
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
9242000 usd
CY2022Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
10737000 usd
CY2023Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
194000 usd
CY2022Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
32000 usd
CY2023Q1 us-gaap Interest Expense
InterestExpense
11393000 usd
CY2022Q1 us-gaap Interest Expense
InterestExpense
10682000 usd
CY2023Q1 us-gaap Asset Impairment Charges
AssetImpairmentCharges
3523000 usd
CY2022Q1 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 usd
CY2023Q1 us-gaap Net Investment In Lease Credit Loss Expense Reversal
NetInvestmentInLeaseCreditLossExpenseReversal
79000 usd
CY2022Q1 us-gaap Net Investment In Lease Credit Loss Expense Reversal
NetInvestmentInLeaseCreditLossExpenseReversal
0 usd
CY2023Q1 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
7879000 usd
CY2022Q1 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
255000 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
7927000 usd
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
24000 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
216000 usd
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
417000 usd
CY2023Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
3604000 usd
CY2022Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
11301000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
11315000 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
10908000 usd
CY2023Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
149000 usd
CY2022Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
286000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
11166000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
10622000 usd
CY2023Q1 us-gaap Participating Securities Distributed And Undistributed Earnings Loss Basic
ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic
72000 usd
CY2022Q1 us-gaap Participating Securities Distributed And Undistributed Earnings Loss Basic
ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic
61000 usd
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
9522000 usd
CY2022Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
8989000 usd
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.03
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.03
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
290080508 shares
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
283640465 shares
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.03
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.03
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
291040466 shares
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
289067778 shares
CY2023Q1 us-gaap Profit Loss
ProfitLoss
11315000 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
10908000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
-3190000 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
12266000 usd
CY2023Q1 us-gaap Oci Equity Method Investment After Tax
OciEquityMethodInvestmentAfterTax
-330000 usd
CY2022Q1 us-gaap Oci Equity Method Investment After Tax
OciEquityMethodInvestmentAfterTax
0 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-3520000 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
12266000 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
7795000 usd
CY2022Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
23174000 usd
CY2023Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
149000 usd
CY2022Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
286000 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
7646000 usd
CY2022Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
22888000 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
2391003000 usd
CY2023Q1 us-gaap Noncontrolling Interest Increase From Subsidiary Equity Issuance
NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance
106000 usd
CY2023Q1 lxp Noncontrolling Interest Decrease From Redemptions For Common Shares
NoncontrollingInterestDecreaseFromRedemptionsForCommonShares
0 usd
CY2023Q1 lxp Common Shares Issuance And Deferred Compensation Costs Amortization
CommonSharesIssuanceAndDeferredCompensationCostsAmortization
2156000 usd
CY2023Q1 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
2076000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Share Based Compensation Forfeited
StockIssuedDuringPeriodValueShareBasedCompensationForfeited
0 usd
CY2023Q1 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.125
CY2023Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
38222000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
11315000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
-3190000 usd
CY2023Q1 us-gaap Oci Equity Method Investment After Tax
OciEquityMethodInvestmentAfterTax
-330000 usd
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
2360762000 usd
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
2323228000 usd
CY2022Q1 us-gaap Noncontrolling Interest Increase From Subsidiary Equity Issuance
NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance
4109000 usd
CY2022Q1 lxp Noncontrolling Interest Decrease From Redemptions For Common Shares Shares
NoncontrollingInterestDecreaseFromRedemptionsForCommonSharesShares
0 shares
CY2022Q1 lxp Noncontrolling Interest Amount Purchased In Consolidated Joint Venture
NoncontrollingInterestAmountPurchasedInConsolidatedJointVenture
27958000 usd
CY2022Q1 lxp Common Shares Issuance And Deferred Compensation Costs Amortization
CommonSharesIssuanceAndDeferredCompensationCostsAmortization
40572000 usd
CY2022Q1 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
6285000 usd
CY2022Q1 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.12
CY2022Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
36358000 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
10908000 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
12266000 usd
CY2022Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
2320482000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
37546000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
42090000 usd
CY2023Q1 us-gaap Payments To Acquire Real Estate
PaymentsToAcquireRealEstate
0 usd
CY2022Q1 us-gaap Payments To Acquire Real Estate
PaymentsToAcquireRealEstate
72148000 usd
CY2023Q1 us-gaap Payments To Develop Real Estate Assets
PaymentsToDevelopRealEstateAssets
34256000 usd
CY2022Q1 us-gaap Payments To Develop Real Estate Assets
PaymentsToDevelopRealEstateAssets
75368000 usd
CY2023Q1 us-gaap Payments For Construction In Process
PaymentsForConstructionInProcess
3703000 usd
CY2022Q1 us-gaap Payments For Construction In Process
PaymentsForConstructionInProcess
5991000 usd
CY2023Q1 us-gaap Proceeds From Sale Of Real Estate Heldforinvestment
ProceedsFromSaleOfRealEstateHeldforinvestment
27338000 usd
CY2022Q1 us-gaap Proceeds From Sale Of Real Estate Heldforinvestment
ProceedsFromSaleOfRealEstateHeldforinvestment
255000 usd
CY2023Q1 us-gaap Proceeds From Collection Of Loans Receivable
ProceedsFromCollectionOfLoansReceivable
1462000 usd
CY2022Q1 us-gaap Proceeds From Collection Of Loans Receivable
ProceedsFromCollectionOfLoansReceivable
7000 usd
CY2023Q1 us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
451000 usd
CY2022Q1 us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
121000 usd
CY2023Q1 us-gaap Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital
ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital
4736000 usd
CY2022Q1 us-gaap Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital
ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital
1537000 usd
CY2023Q1 us-gaap Payments For Leasing Costs
PaymentsForLeasingCosts
410000 usd
CY2022Q1 us-gaap Payments For Leasing Costs
PaymentsForLeasingCosts
536000 usd
CY2023Q1 us-gaap Payments For Proceeds From Deposits On Real Estate Acquisitions
PaymentsForProceedsFromDepositsOnRealEstateAcquisitions
245000 usd
CY2022Q1 us-gaap Payments For Proceeds From Deposits On Real Estate Acquisitions
PaymentsForProceedsFromDepositsOnRealEstateAcquisitions
167000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-5529000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-152532000 usd
CY2023Q1 us-gaap Payments Of Dividends
PaymentsOfDividends
38207000 usd
CY2022Q1 us-gaap Payments Of Dividends
PaymentsOfDividends
36827000 usd
CY2023Q1 us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
2887000 usd
CY2022Q1 us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
2779000 usd
CY2023Q1 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
25000000 usd
CY2022Q1 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
0 usd
CY2023Q1 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
25000000 usd
CY2022Q1 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
0 usd
CY2023Q1 us-gaap Proceeds From Minority Shareholders
ProceedsFromMinorityShareholders
106000 usd
CY2022Q1 us-gaap Proceeds From Minority Shareholders
ProceedsFromMinorityShareholders
4109000 usd
CY2023Q1 us-gaap Payments To Minority Shareholders
PaymentsToMinorityShareholders
268000 usd
CY2022Q1 us-gaap Payments To Minority Shareholders
PaymentsToMinorityShareholders
172000 usd
CY2023Q1 lxp Payment Tax Withholding Sharebased Payment Arrangementand Issuanceof Common Shares
PaymentTaxWithholdingSharebasedPaymentArrangementandIssuanceofCommonShares
2076000 usd
CY2022Q1 lxp Payment Tax Withholding Sharebased Payment Arrangementand Issuanceof Common Shares
PaymentTaxWithholdingSharebasedPaymentArrangementandIssuanceofCommonShares
6285000 usd
CY2023Q1 lxp Payments To Acquire Additional Interest In Subsidiaries Financing Activities
PaymentsToAcquireAdditionalInterestInSubsidiariesFinancingActivities
0 usd
CY2022Q1 lxp Payments To Acquire Additional Interest In Subsidiaries Financing Activities
PaymentsToAcquireAdditionalInterestInSubsidiariesFinancingActivities
27958000 usd
CY2023Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
-148000 usd
CY2022Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
38495000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-43480000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-31417000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-11463000 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-141859000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
54506000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
191027000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
43043000 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
49168000 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
54390000 usd
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
190926000 usd
CY2022Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
116000 usd
CY2021Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
101000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
54506000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
191027000 usd
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
42923000 usd
CY2022Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
49063000 usd
CY2023Q1 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
120000 usd
CY2022Q1 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
105000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
43043000 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
49168000 usd
CY2023Q1 us-gaap Number Of Real Estate Properties
NumberOfRealEstateProperties
116 property
CY2023Q1 us-gaap Number Of States In Which Entity Operates
NumberOfStatesInWhichEntityOperates
20 state
CY2023Q1 us-gaap Use Of Estimates
UseOfEstimates
<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Use of Estimates.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Management has made a number of significant estimates and assumptions relating to the reporting of assets and liabilities, the disclosure of contingent assets and liabilities and the reported amounts of revenues and expenses to prepare these unaudited condensed consolidated financial statements in conformity with GAAP. These estimates and assumptions are based on management's best estimates and judgment. Management evaluates its estimates and assumptions on an ongoing basis using historical experience and other factors, including the current economic environment. Management adjusts such estimates when facts and circumstances dictate. The most significant estimates made include the recoverability of current and deferred accounts receivable, allocation of property purchase price to tangible and intangible assets acquired and liabilities assumed, the determination of VIEs and which entities should be consolidated, the determination of impairment of long-lived assets and equity method investments, valuation of derivative financial instruments, valuation of awards granted under compensation plans, the determination of the incremental borrowing rate for leases where the Company is the lessee, the determination of the term and fair value of sales-type leases, the estimated credit losses for investments in sales-type leases and the useful lives of long-lived assets. Actual results could differ materially from those estimates.</span>
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
9522000 usd
CY2022Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
8989000 usd
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
290080508 shares
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
283640465 shares
CY2023Q1 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.03
CY2022Q1 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.03
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
9522000 usd
CY2022Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
8989000 usd
CY2023Q1 us-gaap Dilutive Securities Effect On Basic Earnings Per Share Other
DilutiveSecuritiesEffectOnBasicEarningsPerShareOther
3000 usd
CY2022Q1 us-gaap Dilutive Securities Effect On Basic Earnings Per Share Other
DilutiveSecuritiesEffectOnBasicEarningsPerShareOther
0 usd
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
9525000 usd
CY2022Q1 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
8989000 usd
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
290080508 shares
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
283640465 shares
CY2023Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
127871 shares
CY2022Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1078891 shares
CY2023Q1 us-gaap Incremental Common Shares Attributable To Equity Forward Agreements
IncrementalCommonSharesAttributableToEquityForwardAgreements
0 shares
CY2022Q1 us-gaap Incremental Common Shares Attributable To Equity Forward Agreements
IncrementalCommonSharesAttributableToEquityForwardAgreements
4348422 shares
CY2023Q1 lxp Incremental Common Shares Attributable To Operating Partnership Units
IncrementalCommonSharesAttributableToOperatingPartnershipUnits
832087 shares
CY2022Q1 lxp Incremental Common Shares Attributable To Operating Partnership Units
IncrementalCommonSharesAttributableToOperatingPartnershipUnits
0 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
291040466 shares
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
289067778 shares
CY2023Q1 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.03
CY2022Q1 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.03
CY2023Q1 lxp Number Of Buildings
NumberOfBuildings
2 building
CY2023Q1 us-gaap Construction In Progress Gross
ConstructionInProgressGross
349827000 usd
CY2023Q1 lxp Numberof Real Estate Properties Held For Sale
NumberofRealEstatePropertiesHeldForSale
2 property
CY2022Q4 lxp Numberof Real Estate Properties Held For Sale
NumberofRealEstatePropertiesHeldForSale
3 property
CY2023Q1 us-gaap Asset Impairment Charges
AssetImpairmentCharges
3523000 usd
CY2022Q1 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 usd
CY2023Q1 us-gaap Equity Method Investments
EquityMethodInvestments
52571000 usd
CY2022Q4 us-gaap Equity Method Investments
EquityMethodInvestments
58206000 usd
CY2023Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
3604000 usd
CY2022Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
11301000 usd
CY2023Q1 us-gaap Interest Costs Capitalized
InterestCostsCapitalized
1996000 usd
CY2022Q1 us-gaap Interest Costs Capitalized
InterestCostsCapitalized
1166000 usd
CY2023Q1 us-gaap Interest Rate Cash Flow Hedge Gain Loss To Be Reclassified During Next12 Months Net
InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet
8826000 usd
CY2023Q1 us-gaap Interest Expense
InterestExpense
11393000 usd
CY2022Q1 us-gaap Interest Expense
InterestExpense
10682000 usd
CY2023Q1 lxp Lessor Operating Lease Account Receivable Writeoff
LessorOperatingLeaseAccountReceivableWriteoff
0 usd
CY2022Q1 lxp Lessor Operating Lease Account Receivable Writeoff
LessorOperatingLeaseAccountReceivableWriteoff
84000 usd
CY2022Q1 lxp Cost Incurred Not Incremental To The Execution Of A Lease
CostIncurredNotIncrementalToTheExecutionOfALease
0 usd
CY2023Q1 lxp Cost Incurred Not Incremental To The Execution Of A Lease
CostIncurredNotIncrementalToTheExecutionOfALease
0 usd
CY2023Q1 lxp Number Of Ground Leases
NumberOfGroundLeases
1 groundlease
CY2023Q1 lxp Number Of Acres Industrial Development Land Parcel
NumberOfAcresIndustrialDevelopmentLandParcel
100 acre
CY2023Q1 us-gaap Sales Type Lease Interest Income
SalesTypeLeaseInterestIncome
1833000 usd
CY2023Q1 us-gaap Operating Lease Lease Income Lease Payments
OperatingLeaseLeaseIncomeLeasePayments
68087000 usd
CY2022Q1 us-gaap Operating Lease Lease Income Lease Payments
OperatingLeaseLeaseIncomeLeasePayments
66982000 usd
CY2023Q1 us-gaap Sales Type Lease Revenue
SalesTypeLeaseRevenue
1833000 usd
CY2022Q1 us-gaap Sales Type Lease Revenue
SalesTypeLeaseRevenue
0 usd
CY2023Q1 us-gaap Operating Lease Variable Lease Income
OperatingLeaseVariableLeaseIncome
13497000 usd
CY2022Q1 us-gaap Operating Lease Variable Lease Income
OperatingLeaseVariableLeaseIncome
11554000 usd
CY2023Q1 us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
83417000 usd
CY2022Q1 us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
78536000 usd
CY2023Q1 us-gaap Lessor Operating Lease Payments To Be Received Remainder Of Fiscal Year
LessorOperatingLeasePaymentsToBeReceivedRemainderOfFiscalYear
199952000 usd
CY2023Q1 us-gaap Sales Type And Direct Financing Leases Lease Receivable Payments To Be Received Remainder Of Fiscal Year
SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedRemainderOfFiscalYear
3921000 usd
CY2023Q1 us-gaap Lessor Operating Lease Payments To Be Received Next Twelve Months
LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths
251668000 usd
CY2023Q1 us-gaap Sales Type And Direct Financing Leases Lease Receivable Payments To Be Received Next Twelve Months
SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedNextTwelveMonths
5263000 usd
CY2023Q1 us-gaap Lessor Operating Lease Payments To Be Received Two Years
LessorOperatingLeasePaymentsToBeReceivedTwoYears
234021000 usd
CY2023Q1 us-gaap Sales Type And Direct Financing Leases Lease Receivable Payments To Be Received Two Years
SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedTwoYears
5473000 usd
CY2023Q1 us-gaap Lessor Operating Lease Payments To Be Received Three Years
LessorOperatingLeasePaymentsToBeReceivedThreeYears
214776000 usd
CY2023Q1 us-gaap Sales Type And Direct Financing Leases Lease Receivable Payments To Be Received Three Years
SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedThreeYears
5692000 usd
CY2023Q1 us-gaap Lessor Operating Lease Payments To Be Received Four Years
LessorOperatingLeasePaymentsToBeReceivedFourYears
178082000 usd
CY2023Q1 us-gaap Sales Type And Direct Financing Leases Lease Receivable Payments To Be Received Four Years
SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedFourYears
5920000 usd
CY2023Q1 us-gaap Lessor Operating Lease Payments To Be Received Five Years
LessorOperatingLeasePaymentsToBeReceivedFiveYears
147815000 usd
CY2023Q1 us-gaap Sales Type And Direct Financing Leases Lease Receivable Payments To Be Received Five Years
SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedFiveYears
6156000 usd
CY2023Q1 us-gaap Lessor Operating Lease Payments To Be Received Thereafter
LessorOperatingLeasePaymentsToBeReceivedThereafter
500439000 usd
CY2023Q1 us-gaap Sales Type And Direct Financing Leases Lease Receivable Payments To Be Received Thereafter
SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedThereafter
733006000 usd
CY2023Q1 us-gaap Lessor Operating Lease Payments To Be Received
LessorOperatingLeasePaymentsToBeReceived
1726753000 usd
CY2023Q1 us-gaap Sales Type And Direct Financing Leases Lease Receivable Payments To Be Received
SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived
765431000 usd
CY2023Q1 us-gaap Sales Type And Direct Financing Leases Lease Receivable Undiscounted Excess Amount
SalesTypeAndDirectFinancingLeasesLeaseReceivableUndiscountedExcessAmount
703579000 usd
CY2023Q1 us-gaap Sales Type And Direct Financing Leases Lease Receivable
SalesTypeAndDirectFinancingLeasesLeaseReceivable
61852000 usd
CY2023Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P9Y2M12D
CY2022Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P9Y6M
CY2023Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.040
CY2022Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.040
CY2023Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
1263000 usd
CY2023Q1 us-gaap Variable Lease Cost
VariableLeaseCost
46000 usd
CY2023Q1 us-gaap Lease Cost
LeaseCost
1309000 usd
CY2022Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
1263000 usd
CY2022Q1 us-gaap Variable Lease Cost
VariableLeaseCost
35000 usd
CY2022Q1 us-gaap Lease Cost
LeaseCost
1298000 usd
CY2023Q1 us-gaap Sublease Income
SubleaseIncome
830000 usd
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
3914000 usd
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
5199000 usd
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
5204000 usd
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
4174000 usd
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
3673000 usd
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
1061000 usd
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
6440000 usd
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
29665000 usd
CY2023Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
5680000 usd
CY2023Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
23985000 usd
CY2023Q1 us-gaap Sales Type Lease Net Investment In Lease Allowance For Credit Loss
SalesTypeLeaseNetInvestmentInLeaseAllowanceForCreditLoss
172000 usd
CY2022Q1 us-gaap Sales Type Lease Net Investment In Lease Allowance For Credit Loss
SalesTypeLeaseNetInvestmentInLeaseAllowanceForCreditLoss
0 usd
CY2022Q4 us-gaap Sales Type Lease Net Investment In Lease Allowance For Credit Loss
SalesTypeLeaseNetInvestmentInLeaseAllowanceForCreditLoss
93000 usd
CY2023Q1 us-gaap Sales Type Lease Net Investment In Lease Allowance For Credit Loss Writeoff
SalesTypeLeaseNetInvestmentInLeaseAllowanceForCreditLossWriteoff
0 usd
CY2023Q1 us-gaap Sales Type Lease Impairment Loss
SalesTypeLeaseImpairmentLoss
79000 usd
CY2023Q1 us-gaap Sales Type Lease Net Investment In Lease Allowance For Credit Loss
SalesTypeLeaseNetInvestmentInLeaseAllowanceForCreditLoss
172000 usd
CY2023Q1 us-gaap Sales Type Lease Net Investment In Lease
SalesTypeLeaseNetInvestmentInLease
61852000 usd
CY2023Q1 us-gaap Sales Type Lease Net Investment In Lease Allowance For Credit Loss
SalesTypeLeaseNetInvestmentInLeaseAllowanceForCreditLoss
172000 usd
CY2023Q1 us-gaap Sales Type Lease Net Investment In Lease After Allowance For Credit Loss
SalesTypeLeaseNetInvestmentInLeaseAfterAllowanceForCreditLoss
61680000 usd
CY2023Q1 lxp Sales Type Lease Net Investment In Lease Allowance For Credit Loss To Total Percent
SalesTypeLeaseNetInvestmentInLeaseAllowanceForCreditLossToTotalPercent
0.0028
CY2022Q3 us-gaap Stock Repurchase Program Number Of Shares Authorized To Be Repurchased
StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased
10000000 shares
CY2022Q1 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
0 shares
CY2023Q1 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
0 shares
CY2023Q1 us-gaap Stock Repurchase Program Remaining Number Of Shares Authorized To Be Repurchased
StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased
6874241 shares
CY2023Q1 lxp Unsettled Repurchases
UnsettledRepurchases
0 usd
CY2022Q1 us-gaap Consolidation Less Than Wholly Owned Subsidiary Parent Ownership Interest Change Due To Net Income Attributable To Parent And Effects Of Changes Net
ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangeDueToNetIncomeAttributableToParentAndEffectsOfChangesNet
10658000 usd
CY2023Q1 lxp Partners Capital Equivalent In Common Shares
PartnersCapitalEquivalentInCommonShares
1.13
CY2023Q1 lxp Partners Capital Account Shares Issued For Units Redeemed
PartnersCapitalAccountSharesIssuedForUnitsRedeemed
3572 shares
CY2022Q1 lxp Partners Capital Account Shares Issued For Units Redeemed
PartnersCapitalAccountSharesIssuedForUnitsRedeemed
6708 shares
CY2023Q1 us-gaap Partners Capital Account Exchanges And Conversions
PartnersCapitalAccountExchangesAndConversions
18000 usd
CY2022Q1 us-gaap Partners Capital Account Exchanges And Conversions
PartnersCapitalAccountExchangesAndConversions
36000 usd
CY2023Q1 us-gaap Partners Capital Account Units
PartnersCapitalAccountUnits
736000 shares
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
11166000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
10622000 usd
CY2023Q1 lxp Consolidation Less Than Wholly Owned Subsidiary Parent Ownership Interest Changes Redemption Of Interest
ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesRedemptionOfInterest
18000 usd
CY2022Q1 lxp Consolidation Less Than Wholly Owned Subsidiary Parent Ownership Interest Changes Redemption Of Interest
ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesRedemptionOfInterest
36000 usd
CY2023Q1 us-gaap Consolidation Less Than Wholly Owned Subsidiary Parent Ownership Interest Change Due To Net Income Attributable To Parent And Effects Of Changes Net
ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangeDueToNetIncomeAttributableToParentAndEffectsOfChangesNet
11184000 usd
CY2023Q1 us-gaap Interest Paid Net
InterestPaidNet
11320000 usd
CY2022Q1 us-gaap Interest Paid Net
InterestPaidNet
9261000 usd
CY2023Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
126000 usd
CY2022Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
36000 usd
CY2023Q1 lxp Noncash Investment Increased Investment In Real Estate Under Construction
NoncashInvestmentIncreasedInvestmentInRealEstateUnderConstruction
34924000 usd
CY2022Q1 lxp Noncash Investment Increased Investment In Real Estate Under Construction
NoncashInvestmentIncreasedInvestmentInRealEstateUnderConstruction
40985000 usd

Files In Submission

Name View Source Status
0001444838-23-000011-index-headers.html Edgar Link pending
0001444838-23-000011-index.html Edgar Link pending
0001444838-23-000011.txt Edgar Link pending
0001444838-23-000011-xbrl.zip Edgar Link pending
ex311-2023331.htm Edgar Link pending
ex312-2023331.htm Edgar Link pending
ex321-2023331.htm Edgar Link pending
ex322-2023331.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
lxp-20230331.htm Edgar Link pending
lxp-20230331.xsd Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
lxp-20230331_cal.xml Edgar Link unprocessable
lxp-20230331_lab.xml Edgar Link unprocessable
lxp-20230331_htm.xml Edgar Link completed
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
lxp-20230331_def.xml Edgar Link unprocessable
lxp-20230331_pre.xml Edgar Link unprocessable